1. charlie4500kelly
2. bcavage
3. falkev01
4. geocansan
5. DontGiveMeLip
1.bcavage 07/17/2018
Enters strategic alliance with Tasly Pharmaceutical Group; will receive $40 mln on closing
2.geocansan 08/30/2018
Mesoblast Provides Update on Transaction With Tasly Pharmaceutical Group
3.charlie4500kelly 05/31/2018
Financial Results and Operational Highlights for the Third Quarter Ended March 31, 2018
4.bcavage 05/29/2018
Mesoblast Partners With Cartherics to Develop 'off-the-shelf' Cell-based Immunotherapies for Solid Cancers
5.falkev01 04/19/2018
Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart Failure
6.falkev01 02/21/2018
Big moves ahead
7.DontGiveMeLip 06/07/2018
H.C. Wainwright & Co. initiates coverage with Buy rating, $17 PT
8.charlie4500kelly 02/21/2018
OK let's see what happens now......
9.charlie4500kelly 03/29/2018
Mesoblast Phase 3 Cell Therapy Trial for Chronic Low Back Pain Completes Enrollment
10.charlie4500kelly 10/02/2018
Trial Results of Mesoblast Cell Therapy in End-Stage Heart Failure Selected as Late-Breaking Presentation at 2018 American Heart Association Scientific Sessions
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW